Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The designation "No specific endogenous RNA or protein" is used in pharmacological contexts to describe therapeutic agents that do not achieve their effect by binding to a specific biological macromolecule. Instead of interacting with a defined receptor or enzyme, these drugs typically work through direct chemical or physical processes (ChEMBL Database, 2024). For example, antacids like aluminum hydroxide neutralize hydrochloric acid in the stomach via a simple acid-base reaction, while osmotic diuretics like mannitol create a physical pressure gradient to move water (DrugBank Online, 2024). Other agents in this category include activated charcoal, which adsorbs toxins, and certain surfactants like simethicone that alter the surface tension of gas bubbles. Because these substances lack a specific protein target, they are often excluded from traditional high-throughput screening and structure-activity relationship (SAR) studies. This classification is vital for data curation in bioinformatics to distinguish between targeted drugs and those with non-specific modes of action (StatPearls, 2023). Furthermore, the safety profiles of these agents are often related to systemic physiological changes, such as electrolyte imbalances, rather than off-target protein binding.
Chemical neutralization, osmotic gradient formation, physical adsorption, or non-specific membrane perturbation
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on No specific endogenous RNA or protein.